Trial Profile
Phase 1 clinical trial to evaluate the safety, tolerability, and pharmacokinetics of single ascending and multiple ascending oral doses of RV521 as well as the effect of food on drug absorption
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2017
Price :
$35
*
At a glance
- Drugs Sisunatovir (Primary)
- Indications Respiratory syncytial virus infections
- Focus Adverse reactions